Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 4.85 B

Elevance Health Inc. Operating Cash Flow is USD 4.85 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 35.77% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.57 B, a -71.04% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 12.33 B, a 46.75% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 8.40 B, a -21.33% change year over year.
  • Elevance Health Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 10.68 B, a 53.73% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities